Related Experiment Video
Updated: Jul 4, 2025

08:15
Fully Human Tumor-based Matrix in Three-dimensional Spheroid Invasion Assay
Published on: May 7, 2019
15.6K
Artificial tumor matrices and bioengineered tools for tumoroid generation.
Yung-Chiang Liu1, Ping Chen2,3, Ray Chang1
1Oujiang Laboratory; Key Laboratory of Alzheimer's Disease of Zhejiang Province, Institute of Aging, Wenzhou Medical University, Wenzhou, Zhejiang 325024, People's Republic of China.
Biofabrication
|February 2, 2024
Summary
Artificial tumors, or tumoroids, are crucial for understanding cancer and developing therapies. This review covers methods for creating tumoroids using various materials and biofabrication techniques to advance cancer research.
Area of Science:
- Biomedical Engineering
- Cancer Biology
- Tissue Engineering
Background:
- The tumor microenvironment (TME) significantly influences tumor progression and metastasis.
- Understanding the TME is vital for developing effective cancer therapies.
- Artificial tumors, or tumoroids, offer a platform to study tumorigenesis and preclinical cancer treatment.
Purpose of the Study:
- To review current methods for constructing tumoroids for preclinical applications.
- To discuss artificial matrix materials and biofabrication techniques used in tumoroid development.
- To identify limitations of current tumoroids and propose future solutions.
Main Methods:
- Tumoroid construction methods including tumor tissue slices and co-culture systems.
- Utilization of natural and synthetic artificial matrix materials.
- Application of biofabrication techniques such as cell assembly, bioengineered tools, bioprinting, and microfluidic devices.
Main Results:
- Current tumoroid fabrication relies on interdisciplinary approaches combining cells and matrix components.
- Various natural and synthetic materials are employed as artificial matrices.
- Biofabrication techniques enable the precise assembly of tumor components.
Conclusions:
- Tumoroids are significant tools for understanding cancer biology and developing clinical therapies.
- Addressing current limitations in tumoroid technology is essential for advancing the field.
- Next-generation tumoroids hold great potential for basic research and clinical applications.

